Injection of the assets are a requirement to the deal, but that does not mean the noteholders are the ones who asked for it. SeD is going to receive shares in the Company in return for injecting the asset based on the value of the asset and SeD is going to decide which asset they are going to inject. SeD obviously is the one who approached AMBS with this deal and offered it to the noteholders. The note holders didn't come to AMBS and say " yes we are agreeable to this deal but you guys have to go out and get another asset first- and by they way issue some more stock which will dilllute us more to do it"
(3)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links